Anthony Macaluso, MD
Colon & Rectal Surgery · Dallas, TXNPI 1649201385
Payments from drug & device makers
What this record shows
This record is dominated by education: $15,000 of the $20,118 with a category attached, or 74.6%. Intuitive Surgical accounts for 89.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $10,664 and has fallen 96.4% since, to $380 in 2025.
Across 74 payments — averaging $271.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$18K
- Johnson & Johnson$405
- Axonics, Inc.$331
- Medtronic$271
- Abbott$133
- GSK$120
- plus $800 from 21 others
What the payments were for
- Travel & lodging$1,5578%
- Food & beverage$3,53918%
- Education$15,00075%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 35 | $18,057 |
| Johnson & Johnson | 5 | $405 |
| Axonics, Inc. | 4 | $331 |
| Medtronic | 1 | $271 |
| Abbott | 1 | $133 |
| GSK | 1 | $120 |
| Sirtex Medical Inc | 1 | $116 |
| Aimmune Therapeutics, Inc. | 1 | $100 |
| THD America, Inc. | 1 | $98 |
| Smith+Nephew | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Conmed Corporation | 1 | $45 |
| Innovation Technologies Inc | 1 | $35 |
| Zyla Life Sciences, Inc. | 2 | $30 |
| Myriad Genetic Laboratories, Inc. | 1 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Activ Surgical, Inc. | 1 | $28 |
| Acell, Inc. | 2 | $26 |
| Davol Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Cook Biotech Incorporated | 1 | $20 |
| Acera Surgical, Inc. | 1 | $17 |
| AbbVie | 1 | $15 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Covidien LP | 1 | $15 |
| Stryker | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$9,000
- Da Vinci Surgical System$8,518
- Axonics$282
- TurboHawk$271
- Echelon Flex$236
- FREESTYLE LIBRE 3$133
- SHINGRIX$120
- SIR-Spheres Microspheres$116
- ZENPEP$100
How this compares
$20,118 in reported general payments places this provider in the 80th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $407 |
| Neomycin Sulfate | 31 | $171 |
| Metronidazole | 38 | $88 |
| Alprazolam | 17 | $52 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Dallas
- Robert JacobsonDallas$125K
- Katerina WellsDallas$83K
- Anand LodhaDallas$40K
- Roberto Rodriguez-RuesgaDallas$38K
- Michael PendolaDallas$21K
- Sarah StringfieldDallas$19K
- Zachary RobertsDallas$17K
- Edward FrankoDallas$13K
- Lai XueDallas$13K
- Nathaniel NgDallas$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.